Market Overview

UPDATE: Benchmark Company Reiterates Buy Rating, Lowers PT on Analogic Corporation

Related ALOG
Analogic Settles Distributor Inquiry
The Market In 5 Minutes: Draghi, iPhones And Warriors

In a report published Wednesday, Benchmark Company reiterated its Buy rating on Analogic Corporation (NASDAQ: ALOG), but lowered its price target from $90.00 to $87.00.

Benchmark Company noted, “We are transitioning coverage of ALOG from the Defense & Homeland Security industry to the Medical Device industry. We believe that this transition better represents ALOG's business model, as 88% of ALOG's fiscal 2012 revenue was driven by their Medical Imaging and Ultrasound business while 12% of ALOG's revenue was driven by Security Technology.”

Analogic Corporation closed on Tuesday at $73.07.

Latest Ratings for ALOG

Mar 2016Sidoti & Co.Initiates Coverage onNeutral
Mar 2016Brean CapitalMaintainsBuy
Mar 2015Wells FargoUpgradesMarket PerformOutperform

View More Analyst Ratings for ALOG
View the Latest Analyst Ratings

Posted-In: Benchmark CompanyAnalyst Color Price Target Analyst Ratings


Related Articles (ALOG)

View Comments and Join the Discussion!